
The Index tracked by the Fund is the MVIS US Listed Biotech 25 Index, which seeks to achieve the same investment performance as the Index before deducting various fees and expenses. The index is designed to track the overall performance of companies involved in the development and production of drugs based on genetic analysis and diagnostic equipment.